Summary Of Significant Accounting Policies (Narrative) (Details) - USD ($)	12 Months Ended
	Jun. 30, 2017	Jun. 30, 2017	Jun. 30, 2016
Allowance for accounts receivable	$ 10,493	$ 10,493	$ 45,584
Deferred revenue	628,136	$ 628,136	331,644
Research and development costs	0		0
Advertising costs	5,854		57,654
Depreciation expenses	$ 25,371		$ 21,721
Stock Options [Member]
Antidilutive securities excluded from computation of earnings per share	123,000,000		123,000,000
Series A Preferred Stock [Member]
Antidilutive securities excluded from computation of earnings per share		10,000	10,000
Series A Preferred Stock [Member] | Common Stock
Common shares issuable upon conversion of preferred shares	100,000,000		100,000,000
Series B Preferred Stock [Member]
Antidilutive securities excluded from computation of earnings per share		18,025	18,025
Series B Preferred Stock [Member] | Common Stock
Common shares issuable upon conversion of preferred shares	450,625,000		450,625,000
Convertible Notes [Member]
Antidilutive securities excluded from computation of earnings per share	23,421,500		21,771,500
Convertible note outstanding value excluded from computation of earnings per share	$ 93,686		$ 87,086